FDA approves Ebglyss for moderate-to-severe atopic dermatitis
The U.S. Food and Drug Administration has approved Eli Lilly's Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 ...
FDA Approves New Biologic Treatment For Atopic Dermatitis, Know How It Can Help Achieve Clear Skin
The FDA has approved Ebglyss (lebrikizumab-lbkz), a new biologic treatment for moderate-to-severe atopic dermatitis in people ...
Healthshots on MSN5d
6 reasons behind your dry, itchy skin – and how to prevent it
Do you often find yourself constantly scratching your skin because it feels dry and uncomfortable? Dry, itchy skin is a ...
Adbry® (tralokinumab-ldrm) Autoinjector Now Available for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis (AD) in the U.S.
LEO Pharma Inc. announced today the availability of the Adbry® (tralokinumab-ldrm) 300 mg/2 mL single-dose autoinjector in ...